What are some of the biggest challenges related to the development & delivery of RNA therapeutics?

RNA
Watch On Demand

In this roundtable, moderated by DDW and sponsored by Azenta Life Sciences, learn about the biggest challenges related to the delivery of RNA therapeutics.

Roundtable panellists include Dr Philip Cruz, UK Medical Director, Moderna, Dr Neill Liptrott, Reader in Pharmacology and Immuno-compatability, University of Liverpool, and Reece Armstrong, Editor, DDW.

Philip Cruz
Philip Cruz
Dr Neill Liptrott
Dr Neill Liptrott
Reece Armstrong
Reece Armstrong

 

 

 

 

 

 

 

Panellists address the following questions:

  • How has the Covid-19 pandemic influenced the advancement of RNA research?
  • What does the investment landscape look like for RNA therapeutics after Covid?
  • What are some of the biggest challenges related to the delivery of RNA therapeutics?
  • What does the RNA pipeline look like across disease areas?

The roundtable discussion is followed by a Q&A, and includes a presentation from Andrea O’Hara, PhD, Strategic Technical Specialist, Azenta Life Sciences.

Related Articles